md-medicaldata


Go to content

TRANZICIJA OBOLELIH OD HRONIČNE INFLAMATORNE BOLESTI CREVA: MOST ILI PREPREKA
TRANSITION PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A BRIDGE OR BARRIERS

Authors

 

Mirjana Stojšić1,2 , Jelena Lazić1

1Institut za zdravstvenu zaštitu dece i omladine Vojvodine, Novi Sad, Srbija
2Medicinski fakultet Univerziteta u Novom Sadu, Srbija

 


The paper was received on 20.02.2017/ Accepted on 28.02.2017.

 


Correspondence to


Mirjana Stojšić, MD, PhD
pediatrician-gastroenterohepatologist
Chief of Cabinet for GI endoscopy
Department of gastroenterology, hepatology and nutrition
Institute of Child and Youth Health Care of Voyvodina
Hajduk Veljkova 10, 21000 Novi Sad, Serbia
mobile : +381 62 20 33 40
e-mail: drstojsic@gmail.com

 

 

Abstract

 

The process in which adolescents with chronic inflammatory bowel disease (IBD) prepare for the transition from health care focused on children, to the ones that focus on adults are called transition patients IBD. Transitional medicine is not only simple for transferring patients from pediatric services to internists work. This new field of medicine is actually a complex regulated process that the pediatrician begins early, and it aims to make patients independent in managing their own health and diseases.
Key parts in the period of transition are the patient, parent, pediatrician and internist. Their interaction leads to success in overcoming the challenges of transition. The coordinator of the transition should be the pediatrician gastroenterologist specialist IBD or the nurse that specializes in working with patients with IBD. The role of the coordinator of the transition has been writing and overseeing the transition plan, co-ordinate the transition process, deciding when should the transfer be done formally and support all participants of the transition, with the aim to ensure the successful completion of the transition. All the key parts in the process of transition may have obstacles to its successful acquisition and potential obstacles can be: emotional, external and internal.
Every adolescent should be included in the transitional programs that can be adapted to local organizations of the pediatric and internal medicine. The time of the transition should be individually adjusted to the psychosocial preparedness of the patient between the 12 and 18-years of age.
Further research in this area should aim to identify the best and most cost-effective models for planning the transition, and to prove that the transitional programs improve health outcomes, the patients quality of life and represent cost savings for the health system.

 

Key words

Transition, inflammatory bowel disease, child, adolescent

 

 

Sažetak

 

Proces u kome se adolescenti sa hroničnom inflamatornom bolesti creva (HIBC) pripremaju za prelazak sa zdravstvene zaštite fokusirane na decu, ka onoj fokusiranoj na odrasle osobe nazivamo tranzicijom obolelih od HIBC.Tranziciona medicina  nije samo prost prenos ili transfer bolesnika iz pedijatrijske službe ka internističkoj službi. Ova nova oblast medicine zapravo predstavlja kompleksan uređen proces, koji rano započinje pedijatar, a ima za cilj da učine pacijente nezavisnim u upravljanju sopstvenim zdavljem i bolestima.
Ključne strane u periodu tranzicije su bolesnik, roditelj, pedijatar i internista. Njihova interakcija vodi uspešnom savlađivanju izazova tranzicije.Koordinator tranzicije bi trebalo da bude pediajtar gastroenterolog specijalista za HIBC ili medicinska sestra specijalizovana za rad sa obolelima sa HIBC. Uloga koordinatora tranzicije jepisanje i nadgledanje tranzicionog plana, koordinira procesa tranzicije, odlučivanje kada bi trebalo da se formalno obavi transfer i pružanje podrške svim učesnicima tranzicije, a sa ciljem da se osigura uspešan završetak tranzicije.
Sve ključne strane u procesu tranzicije mogu imati prepreke za njeno uspešno savlađivanje, a potencijalne prepreke mogu biti: emotivne, spoljne i unutrašnje.
Svaki adolescent treba da budu uključen u tranzicione programe koji se mogu prilagoditi lokalnim organizacijima pedijatrijske i interne medicine. Vreme tranzicije treba individualno prilagoditi psihosocijalnoj spremnosti bolesnika između 12. i 18. godine starosti.
Dalja istraživanja u ovoj oblasti treba da identifikuju najbolje i najekonomičnije modele za planiranje tranzicije, odnosno da dokažu  da tranzicioni programi  poboljšavaju zdravstvene ishode, kvalitet života pacijenta i predstavljaju uštede za zdravstveni sistem.

 

 

Ključne reči:

tranzicija, hronična inflamatorna bolest creva, dete, adolescent

 

 

 

References

 

  1. Blum RW, Garell D, Hodgman CH, Jorissen TW, Okinow NA., Orr DP, et al. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. J Adolesc Heal. 1993;14(7):570–6.
  2. David TJ. Transition from paediatric clinic to the adult service. J R Soc Med. 2001;94(8):373–4.
  3. Hait E, Arnold JH, Fishman LN. Educate, communicate, anticipate - Practical recommendations for transitioning adolescents with IBD to adult health care. Inflamm Bowel Dis [Internet]. 2006;12(1):70–3. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed7&AN=2006010987%5Cnhttp://openurl.ac.uk/athens:lee/?sid=OVID:embase&id=pmid:&id=doi:10.1097/01.MIB.0000194182.85047.6a&issn=1078-0998&isbn=&volume=12&issue=1&spage=70&pages=70-73&dat
  4. Baldassano R, Ferry G, Griffiths A, Mack D, Markowitz J, Winter H. Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2002;34(3):245–8.
  5. Goodhand J, Dawson R, Hefferon M, Tshuma N, Swanson G, Wahed M, et al. Inflammatory bowel disease in young people: The case for transitional clinics. Inflamm Bowel Dis. 2010;16(6):947–52.
  6. Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, et al. Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease. Gastroenterology. 2008;135(4):1114–22.
  7. Abraham BP, Kahn SA. Transition of care in inflammatory bowel disease. Gastroenterol Hepatol. 2014;10(10):633–40.
  8. Mamula P, Telega GW, Markowitz JE, Brown K a, Russo P a, Piccoli D a, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol. 2002;97(8):2005–10.
  9. Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, et al. Natural History of Pediatric Crohn’s Disease: A Population-Based Cohort Study. Gastroenterology. 2008;135(4):1106–13.
  10. Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology [Internet]. Elsevier, Inc; 2014;147(5):990–1007. Available from: http://dx.doi.org/10.1053/j.gastro.2014.07.023
  11. Crandall W V, Baldassano R, Bousvaros A, Denson LA, Gupta N, Mackner LM. NASPGHAN Single-Topic Symposium. J Pediatr Gastroenterol Nutr [Internet]. 2014 Jan;58(1):130–8. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3889135&tool=pmcentrez&rendertype=abstract
  12. Phavichitr N, Cameron DJS, Catto-Smith AG. Increasing incidence of Crohn’s disease in Victorian children. J Gastroenterol Hepatol. 2003;18(3):329–32.
  13. Hommel KA, Greenley RN, Maddux MH, Gray WN, Mackner LM. Self-management in pediatric inflammatory bowel disease: A clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr [Internet]. 2013;57(2):250–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23648790%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3723797
  14. Hommel KA, Davis CM, Baldassano RN. Objective versus Subjective Assessment of Oral Medication Adherence in Pediatric Inflammatory Bowel Disease. Inflamm Bowel DisRatio. 2009;15(4):589–93.
  15. Mackner LM, Crandall W V, Szigethy EM. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(3):239–44.
  16. Van de star T, Banan A. Role of Psychosocial Factors on the Course of Inflammatory Bowel Disease and Associated Psychotherapeutic Approaches. A Fresh Perspective and Review. Gastroenterol Hepatol  Open Access [Internet]. 2015;2(2):38. Available from: http://medcraveonline.com/GHOA/GHOA-02-00038.php
  17. Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of Pediatric Ulcerative Colitis. J Pediatr Gastroenterol Nutr [Internet]. 2012;55(3):340–61. Available from: papers2://publication/doi/10.1097/MPG.0b013e3182662233
  18. Greenley RN, Stephens M, Doughty A, Raboin T, Kugathasan S. Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(1):36–41.
  19. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int [Internet]. 2000;15(3):259–67. Available from: http://heapro.oxfordjournals.org/content/15/3/259
  20. Lisa M. Ingerski, Baldassano RN, Denson LA, Hommel KA. Barriers to oral medication adherence in pediatric inflammatory bowel disease (IBD). Gastroenterology [Internet]. 2010;35(6):683–91. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L70396257%0Ahttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=00165085&id=doi:&atitle=Barriers+to+oral+medication+adherence+in+pediatric+inflammatory+bowel+disease+%28IBD%29&stitle=Gast
  21. Ediger JP, Walker JR, Graff L, Lix L, Clara I, Rawsthorne P, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102(7):1417–26.
  22. Kane S V. Strategies to improve adherence and outcomes in patients with ulcerative colitis. Drugs. 2008;68(18):2601–9.
  23. Sewitch M, Abrahamowicz M, Barkun A, Alain Bitton, Wild GE, Cohen A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol [Internet]. 2003 Jul;98(7):1535–44. Available from: http://www.sciencedirect.com/science/article/pii/S0002927003003046
  24. Bernal I, Domènech E, Garcia-Planella E, Marín L, Mañosa M, Mercè Navarro, et al. Medication?taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci. 2006;51(12):2165–9.
  25. Hait EJ, Barendse RM, Arnold JH, Valim C, Sands BE, Korzenik JR, et al. Transition of Adolescents With Inflammatory Bowel Disease From Pediatric to Adult Care: A Survey of Adult Gastroenterologists. J Pediatr Gastroenterol Nutr [Internet]. 2009 Jan;48(1):61–5. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005176-200901000-00010
  26. Leung Y, Heyman MB, Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: Guidelines for the adult and pediatric gastroenterologist. Inflamm Bowel Dis. 2011;17(10):2169–73.
  27. Salmon P, Young B. Dependence and caring in clinical communication: The relevance of attachment and other theories. Patient Educ Couns. 2009;74(3):331–8.
  28. Buscarini E, Conte D, Cannizzaro R, Bazzoli F, De Boni M, Delle Fave G, et al. White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths. Dig Liver Dis. 2014;46(7):579–89.
  29. Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of Pediatric Ulcerative Colitis. J Pediatr Gastroenterol Nutr [Internet]. 2012;55(3):340–61. Available from: papers2://publication/doi/10.1097/MPG.0b013e3182662233
  30. Bollegala N, Nguyen GC. Transitioning the Adolescent with IBD from Pediatric to Adult Care: A Review of the Literature. Gastroenterol Res Pract. Hindawi Publishing Corporation; 2015;2015:853530.

UDK: 616.34-002-083/-085
614.2
COBISS.SR-ID 230572044



PDF Stojšić M. and Lazić J. • MD-Medical Data 2017;9(1): 039-044

 

 

 

Naslovna | Revija | Galerija | Dešavanja | Instrukcije | Redakcija | Izdavač | Prijatelji sajta | Saradnja | Kontakt | Site Map


Back to content | Back to main menu